Ther Clin Risk Manag Volume 1(3); September 2005

Other Issues: previous | next | latest | archive

Volume 1(3); September 2005

Editorial Foreword

EDITORIAL FOREWORD

Garry Walsh

Ther Clin Risk Manag. 2005 September; 1(3): 167. Published online 2005 September.

PMCID: PMC1661626

| Full Text | PDF–25K |

Reviews

Sputum analysis in diagnosis and management of obstructive airway diseases

Paige Lacy, Jennifer L Lee, and Dilini Vethanayagam

Ther Clin Risk Manag. 2005 September; 1(3): 169–179. Published online 2005 September.

PMCID: PMC1661627

| Abstract | Full Text | PDF–397K |

Adverse drug reaction reporting in New Zealand: implications for pharmacists

Monica Zolezzi and Nirasha Parsotam

Ther Clin Risk Manag. 2005 September; 1(3): 181–188. Published online 2005 September.

PMCID: PMC1661625

| Abstract | Full Text | PDF–120K |

The challenge of patient adherence

Leslie R Martin, Summer L Williams, Kelly B Haskard, and M Robin DiMatteo

Ther Clin Risk Manag. 2005 September; 1(3): 189–199. Published online 2005 September.

PMCID: PMC1661624

| Abstract | Full Text | PDF–100K |

Inhibitors of selectin functions in the treatment of inflammatory skin disorders

Michael P Schön

Ther Clin Risk Manag. 2005 September; 1(3): 201–208. Published online 2005 September.

PMCID: PMC1661630

| Abstract | Full Text | PDF–158K |

Original Research

Influence of anatomical site and topical formulation on skin penetration of sunscreens

Heather AE Benson, Vikram Sarveiya, Stacey Risk, and Michael S Roberts

Ther Clin Risk Manag. 2005 September; 1(3): 209–218. Published online 2005 September.

PMCID: PMC1661631

| Abstract | Full Text | PDF–137K |

Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia

Madeleine Nowak, Petra Büttner, Beverly Raasch, Kym Daniell, Cindy McCutchan, and Simone Harrison

Ther Clin Risk Manag. 2005 September; 1(3): 219–224. Published online 2005 September.

PMCID: PMC1661628

| Abstract | Full Text | PDF–67K |

Gastrointestinal bleeding and massive liver damage in neuroleptic malignant syndrome

Guido Mannaioni, Roberto Baronti, and Flavio Moroni

Ther Clin Risk Manag. 2005 September; 1(3): 225–230. Published online 2005 September.

PMCID: PMC1661629

| Abstract | Full Text | PDF–62K |

Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3

Shenxian Qian, George Somlo, Bingsen Zhou, and Yun Yen

Ther Clin Risk Manag. 2005 September; 1(3): 231–241. Published online 2005 September.

PMCID: PMC1661623

| Abstract | Full Text | PDF–563K |

Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese

Xiao Hui Liang, Wai Cheung, Chew Kiat Heng, and De-Yun Wang

Ther Clin Risk Manag. 2005 September; 1(3): 243–246. Published online 2005 September.

PMCID: PMC1661622

| Abstract | Full Text | PDF–99K |

Other Issues: previous | next | latest | archive

		Other Issues: previous \| next \| latest \| archive Volume 1(3); September 2005 Editorial Foreword EDITORIAL FOREWORD Garry Walsh Ther Clin Risk Manag. 2005 September; 1(3): 167. Published online 2005 September. PMCID: PMC1661626 \| Full Text \| PDF–25K \| Reviews Sputum analysis in diagnosis and management of obstructive airway diseases Paige Lacy, Jennifer L Lee, and Dilini Vethanayagam Ther Clin Risk Manag. 2005 September; 1(3): 169–179. Published online 2005 September. PMCID: PMC1661627 \| Abstract \| Full Text \| PDF–397K \| Adverse drug reaction reporting in New Zealand: implications for pharmacists Monica Zolezzi and Nirasha Parsotam Ther Clin Risk Manag. 2005 September; 1(3): 181–188. Published online 2005 September. PMCID: PMC1661625 \| Abstract \| Full Text \| PDF–120K \| The challenge of patient adherence Leslie R Martin, Summer L Williams, Kelly B Haskard, and M Robin DiMatteo Ther Clin Risk Manag. 2005 September; 1(3): 189–199. Published online 2005 September. PMCID: PMC1661624 \| Abstract \| Full Text \| PDF–100K \| Inhibitors of selectin functions in the treatment of inflammatory skin disorders Michael P Schön Ther Clin Risk Manag. 2005 September; 1(3): 201–208. Published online 2005 September. PMCID: PMC1661630 \| Abstract \| Full Text \| PDF–158K \| Original Research Influence of anatomical site and topical formulation on skin penetration of sunscreens Heather AE Benson, Vikram Sarveiya, Stacey Risk, and Michael S Roberts Ther Clin Risk Manag. 2005 September; 1(3): 209–218. Published online 2005 September. PMCID: PMC1661631 \| Abstract \| Full Text \| PDF–137K \| Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia Madeleine Nowak, Petra Büttner, Beverly Raasch, Kym Daniell, Cindy McCutchan, and Simone Harrison Ther Clin Risk Manag. 2005 September; 1(3): 219–224. Published online 2005 September. PMCID: PMC1661628 \| Abstract \| Full Text \| PDF–67K \| Gastrointestinal bleeding and massive liver damage in neuroleptic malignant syndrome Guido Mannaioni, Roberto Baronti, and Flavio Moroni Ther Clin Risk Manag. 2005 September; 1(3): 225–230. Published online 2005 September. PMCID: PMC1661629 \| Abstract \| Full Text \| PDF–62K \| Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3 Shenxian Qian, George Somlo, Bingsen Zhou, and Yun Yen Ther Clin Risk Manag. 2005 September; 1(3): 231–241. Published online 2005 September. PMCID: PMC1661623 \| Abstract \| Full Text \| PDF–563K \| Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese Xiao Hui Liang, Wai Cheung, Chew Kiat Heng, and De-Yun Wang Ther Clin Risk Manag. 2005 September; 1(3): 243–246. Published online 2005 September. PMCID: PMC1661622 \| Abstract \| Full Text \| PDF–99K \|
		Other Issues: previous \| next \| latest \| archive
		Articles from Therapeutics and Clinical Risk Management are provided here courtesy of Dove Press Write to PMC \| PMC Home \| PubMed NCBI \| U.S. National Library of Medicine NIH \| Department of Health and Human Services Privacy Policy \| Disclaimer \| Freedom of Information Act